Median Technologies
Focus: Median Technologies is an imaging phenomics company specializing in AI-powered oncology solutions, including iCRO (imaging central lab) and clinical trial support services. Founded in 2024 and publicly listed, the company operates from Shanghai with a focus on early cancer detection and trial imaging analysis.
Profile data last refreshed 4h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
4
Should You Work at Median Technologies?
AI assessmentMedian Technologies is a high-risk, high-upside early-stage play for candidates seeking exposure to AI-oncology innovation, but financial distress and minimal hiring suggest wait-and-see prudence unless you have deep expertise in imaging biomarkers or iCRO operations.
Why Work Here
- Join a newly public (2024) biotech with cutting-edge AI imaging technology positioning for oncology expansion, as evidenced by recent press on AI-powered lung cancer detection 5 years in advance.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Median LCS
High Risk CancerClinical Trials (1)
NCT06576232Standalone Observational Study Assessing the Performance of an AI/ML Tech-based SaMD on Chest LDCT Images (REALITY)
N/AHelp build intelligence for Median Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.